Literature DB >> 24275450

The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers.

Mohammad Najlah1, Ishrat Parveen2, Mohamed Albed Alhnan2, Waqar Ahmed3, Ahmed Faheem4, David A Phoenix5, Kevin M G Taylor6, Abdelbary Elhissi7.   

Abstract

Using latex microspheres as model suspensions, the influence of suspension particle size (1, 4.5 and 10 μm) on the properties of aerosols produced using Pari LC Sprint (air-jet), Polygreen (ultrasonic), Aeroneb Pro (actively vibrating-mesh) and Omron MicroAir NE-U22 (passively vibrating-mesh) nebulisers was investigated. The performance of the Pari nebuliser was independent of latex spheres particle size. For both Polygreen and Aeroneb Pro nebulizers, total aerosol output increased when the size of latex spheres increased, with highest fine particle fraction (FPF) values being recorded. However, following nebulisation of 1 or 4.5 μm suspensions with the Polygreen device, no particles were detected in the aerosols deposited in a two-stage impinger, suggesting that the aerosols generated from this device consisted mainly of the continuous phase while the dispersed microspheres were excluded and remained in the nebuliser. The Omron nebuliser efficiently nebulised the 1 μm latex spheres, with high output rate and no particle aggregation. However, this device functioned inefficiently when delivering 4.5 or 10 μm suspensions, which was attributed to the mild vibrations of its mesh and/or the blockage of the mesh apertures by the microspheres. The Aeroneb Pro fragmented latex spheres into smaller particles, but uncontrolled aggregation occurred upon nebulisation. This study has shown that the design of the nebuliser influenced the aerosol properties using latex spheres as model suspensions. Moreover, for the recently marketed mesh nebulisers, the performance of the Aeroneb Pro device was less dependent on particle size of the suspension compared with the Omron MicroAir nebuliser.
Copyright © 2013 Elsevier B.V. All rights reserved.

Keywords:  Aerosol; Latex sphere; Nebuliser; Two-stage impinger; Vibrating-mesh

Mesh:

Substances:

Year:  2013        PMID: 24275450     DOI: 10.1016/j.ijpharm.2013.11.022

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  Advances in device and formulation technologies for pulmonary drug delivery.

Authors:  John Gar Yan Chan; Jennifer Wong; Qi Tony Zhou; Sharon Shui Yee Leung; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2014-04-12       Impact factor: 3.246

2.  Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2015-09-30       Impact factor: 2.897

3.  Utility of Three Nebulizers in Investigating the Infectivity of Airborne Viruses.

Authors:  Sadegh Niazi; Lisa K Philp; Kirsten Spann; Graham R Johnson
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

Review 4.  Inhalation drug delivery devices: technology update.

Authors:  Mariam Ibrahim; Rahul Verma; Lucila Garcia-Contreras
Journal:  Med Devices (Auckl)       Date:  2015-02-12

5.  Aerosolization Performance of Jet Nebulizers and Biopharmaceutical Aspects.

Authors:  Greta Adorni; Gerrit Seifert; Francesca Buttini; Gaia Colombo; Luciano A Stecanella; Irene Krämer; Alessandra Rossi
Journal:  Pharmaceutics       Date:  2019-08-11       Impact factor: 6.321

Review 6.  Inhaled Liposomal Antimicrobial Delivery in Lung Infections.

Authors:  Matteo Bassetti; Antonio Vena; Alessandro Russo; Maddalena Peghin
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.